Why The Ovary Cancer Will Come

Ovarian cancer is a silent killer and one of the most deadly threats to women's health. The American Cancer Society reports that 20,180 American women will be diagnosed with ovarian cancer this year alone. All women have a 1:57 risk of ovarian cancer in their lifetime. Symptoms of ovarian cancer go unnoticed until the cancer is widespread and fatal. This explains why thousands of women die each year from this horrific disease. Ovarian cancer is curable, but in most cases it is detected late, leading to complications and death in people with ovarian cancer. Since to date there is no sure and effective way to diagnose or detect ovarian cancer in its early stage, specialists, research groups and cancer advocacy groups and the government organizations are doing every ovarian cancer research work they can to finally shed light into the gray areas of this deadly disease. Some organizations provide grants for those willing and interested to conduct an ovarian cancer research. Among the most prominent organizations that promote awareness on ovarian cancer is the Ovarian Cancer National Alliance. It was formed in 1997 by seven ovarian cancer advocacy groups who joined forces to strengthen efforts to promote ovarian cancer education. Ovarian cancer research teams probe into several areas of ovarian cancer including its symptoms (both in the early and the latter stage), stages, risk factors, prevention, risk reduction, and treatment, with the aim of increasing awareness on this cancer. Knowledge in this area can be a woman's best defense against this cancer. However, research on ovarian cancer is in progress due to the high mortality rate of these cancers along with the fact that there are many gaps in information that have not yet been filled. In the United States, ovarian cancer is the fifth leading gynecological cancer that puts women at risk of death. Studies show that more than 50% of all women diagnosed with the disease die within 5 years. In this regard, the Ovarian Cancer Research Center is trying to uncover the hidden truth of ovarian cancer. Most studies of ovarian cancer show that women with ovarian cancer experience symptoms such as persistent and embarrassing gastrointestinal discomfort, nausea, indigestion, bloating or bloating, abdominal and pelvic pain, fatigue, frequent urination, and abnormal bleeding. During menopause. A recent University of California ovarian cancer study found that more than a third of women diagnosed with ovarian cancer show symptoms at least four months before they are diagnosed. Therefore, there is a great opportunity for early diagnosis of ovarian cancer. Researchers explain that cancer is only discovered at an advanced stage because doctors don't do tests that can diagnose it right away. Doctors regularly give people imaging of the abdomen and some gastrointestinal procedures, which they say are not effective in diagnosing the condition. Other Ovarian Cancer Research focuses on improving the treatment and prevention of ovarian cancer. Numerous clinical trials are being conducted to thoroughly evaluate the drug's potential in preventing ovarian cancer in high-risk women and in treating women with early and advanced cancer.